Table 2 The effects of BBR and its derivatives on weight and lipid profiles
From: Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE−/− mice
Weight (g) | TG (mmol/L) | TC (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) | |
|---|---|---|---|---|---|
Control | 34.2 ± 0.5 | 5 ± 1.1 | 22.9 ± 1.5 | 1.6 ± 0.25 | 5.9 ± 1.12 |
BBR | 33.4 ± 0.7 | 3.9 ± 0.8 | 17.3 ± 2.1* | 1.7 ± 0.31 | 4.8 ± 1.2* |
dhBBR | 32.1 ± 1.2 | 4.2 ± 0.7 | 21.6 ± 1.8 | 1.6 ± 0.29 | 5.1 ± 1.3* |
Di-MeBBR | 33.6 ± 1.7 | 4.4 ± 0.9 | 18.9 ± 1.3* | 1.8 ± 0.32 | 4.5 ± 0.9* |